CCIA
FATE icon

Campbell & Co Investment Adviser’s Fate Therapeutics FATE Stock Holding History

Campbell & Co Investment Adviser’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-324,585
Closed -$1.06M – 1164
2024
Q2 		$1.06M Buy
+324,585
New +$1.42M 0.09% 340
2023
Q2 		– Sell
-59,651
Closed -$340K – 961
2023
Q1 		$340K Buy
59,651
+9,929
+20% +$59.9K 0.06% 564
2022
Q4 		$502K Buy
49,722
+35,290
+245% +$663K 0.12% 313
2022
Q3 		$323K Buy
+14,432
New +$417K 0.07% 457

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return